Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024)

Zentalis Pharmaceuticals (ZNTL) has 1 years of Net Margin data on record, last reported at 176.71% in Q4 2024.

  • For Q4 2024, Net Margin changed N/A year-over-year to 176.71%; the TTM value through Sep 2025 reached 555.8%, down 11339.0%, while the annual FY2024 figure was 246.0%, N/A changed from the prior year.
  • Net Margin reached 176.71% in Q4 2024 per ZNTL's latest filing, down from 24.75% in the prior quarter.
  • Across five years, Net Margin topped out at 24.75% in Q1 2024 and bottomed at 176.71% in Q4 2024.